QUOTE AND NEWS
PR Newswire  Jan 7  Comment 
SHANGHAI, China, Jan. 6 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the United States, today
PR Newswire  Dec 23  Comment 
SHANGHAI, Dec. 22 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology, and medical-device research and development outsourcing company with operations in China and the United States, today announced the winners of
PR Newswire  Dec 22  Comment 
SHANGHAI, Dec. 22 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology, and medical-device research and development outsourcing company, with operations in China and the United States, announced that it had been
PR Newswire  Dec 7  Comment 
SHANGHAI, Dec. 7 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today it has purchased
PR Newswire  Nov 30  Comment 
SHANGHAI, Nov. 30 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology, and medical-device research and development outsourcing company with operations in China and the United States, announced that it had been
StreetInsider.com  Nov 16  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/WuXi+PharmaTech+%28WX%29+Posts+Q3+non-GAAP+EPS+of+%240.24%2C+Tops+by+9c/5115818.html for the full story.
PR Newswire  Nov 16  Comment 
SHANGHAI, Nov. 16 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United
Globe Newswire  Sep 24  Comment 
DALLAS, Sept. 24, 2009 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring pharmaceutical company WuXi PharmaTech (Cayman) Inc. (NYSE:WX). The report includes financial and investment analysis, analyst consensus, and
StreetInsider.com  Aug 13  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/Jefferies+%26+Co+Upgrades+WuXi+PharmaTech+%28WX%29+to+Hold+/4871929.html for the full story.
StreetInsider.com  Aug 11  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Guidance/WuXi+PharmaTech+%28WX%29+Reports+Q2+Non-GAAP+EPS+of+%240.24%2C+Beats+by+12c%3B+Affirms+FY09+Sales+Outlook/4866713.html for the full story.



Thank you for your suggestion


 
WX AT A GLANCE
 
 
 
 
 
 
 
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki